Table 1.
Characteristics of the participants
Age (years, mean±SD) | 49±6 |
Body Mass index (kg/m2, mean±SD) | 28.1±2.9 |
Race: % Caucascian: Latin/Hispanic: African American | 48:47:5 |
CD4 count (cells/ml, median) | 510 |
HIV viral load (% undetectable) | 74 |
Current antiretroviral therapy (%) | |
HAART | 100% |
Protease inhibitor | 57 |
Nucleoside reverse transcriptase inhibitor | 100 |
Non-nucleoside reverse transcriptase inhibitor | 35 |
Hepatitis C co-infection (%) | 22 |